view expect bad wors expect
low-qual beat off-set posit merck
over-the-counter acquisit increment harder us get excit
pg share despit compel valuat pg trade
year low absolut rel basi see lack
catalyst near-term maintain market perform rate
yet anoth low-qual price pressur
continu pg report ep y/i vs
our/con est howev anoth low-qual
beat benefit tax benefit non-
oper incom offset miss oper
consecut quarter
volum driven price worsen vs
neg price persist gross margin
y/i miss estimate expect
turn posit behind signific cost save babi
groom remain challeng requir addit intervent
note organ sale growth ytd would
ex babi groom guidanc pg expect
organ sale growth low-end prior rang
manag hint would like round-up
call ep growth vs prior part due
lower tax rate vs prior maintain
ep estim lower price
target lower organ sale forecast
line headwind continu persist includ slow categori growth
current global heighten
competit environ retail inventori destock
headwind vs share loss continu valu
share though volum share flat y/i
expect organ sale growth improv modestli driven
lap gillett price solid new innov
lower estim prior lag behind
categori growth lower organ sale
growth estim
view merck over-the-counter acquisit posit despit
limit accret impact view
acquisit posit multipl front deal growth
margin accret health segment give pg
scale run global over-the-counter busi keep profit
wind teva joint ventur signal pg
proactiv transform portfolio deal like
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
compani prioriti stock list
exclud restructur cost one-tim item
compani data secur llc estim reuter
past year simplifi
maintain market perform rate procter gambl co pg pg largest
manufactur market consum packag good global pg undergon larg amount
portfolio chang decis
making/incent compens goal improv agil execut believ current
strategi correct one yet seen structur chang benefit top-lin organ
sale growth continu trail peer level share loss continu key countries/categori
competit remain fierc ever pg strategi innov premium end hasnt result
share gain environ consum increasingli price sensit pg deliv
impress product save view margin progress slow believ top-lin
acceler addit sustain margin improv need order expand valuat
next year expect top-lin growth remain mute low singl digit
margin expans continu though slower pace recent year drive mid-single-digit
msd high-single-digit hsd oper incom ep growth ex currenc compar hsd
double-digit dd growth best-in-class peer pg current trade ep
estim discount stapl group vs histor premium
respect believ justifi given below-p organ sale growth downsid risk
current valuat support free cash flow convers dividend yield
reiter market perform rate price target base price-to-earnings
ev/ebitda multipl estim
pg report fiscal ep ep yr/yr
our/consensu estim ebit margin estim
y/i overal anoth low qualiti quarter ep beat below-the-lin
ebit miss off-set non-oper incom tax tax rate
lower estim
pg organ sale growth disappoint estim
estim organ sale growth round slightli calcul our/consensu
estim segment wors expect
organ sale volum driven view weak price signific
concern fiscal organ sale growth entir volum driven addit price
remain neg pg second consecut quarter unround
slowdown vs last quarter pg manag indic gillett price intervent
reduc organ sale note compani start annual price chang
start month expect sale stronger go forward
separ fabric price lower due promot invest pg
emphas maintain competit europ said despit
weak manag optimist price turn posit
benefit price increas pg take price off-set commod cost pressur mix
improv pg bring new innov market nonetheless remain cautiou would
like see balanc approach top-lin growth profit believ addit
price intervent across portfolio could necessari especi consid slow categori
growth heighten competit environ
babi trend still concern babi organ sale growth weak
disappoint -msd broadli reflect trade inventori reduct competit activ
includ reduc competitor price pg acknowledg custom
aggress pursu privat label aggress price phenomenon
challeng compani luv brand pg manag indic compani
alreadi taken step increas luv overal competit step may need given
price case almost area step includ step
market greater in-stor presenc valu adjust need convers pg
optimist china diaper busi note diaper organ sale growth
china quarter first quarter growth quarter even
impress well ahead declin fiscal said illustr
compani invest premium diaper product start move needl work
need done half pg diaper sale china still consist mid-tier tape diaper
segment declin dd rate all-in despit improv china remain concern
pg global diaper busi remain highli cogniz increas pressur
groom wors expect overal concern remain overal groom segment
organ sale growth conserv estim overal
price slightli better estimate howev mix significantli bigger
headwind anticip well well flat estimate said pg manag
tone optimist volum male shave care posit fourth consecut quarter
howev continu take slightli cautiou approach remain
cogniz continu threat includ harri recent launch along shave club
expans europ
inventori destock remain headwind pg manag acknowledg retail
inde focus ration inventori level said part headwind due pg
improv suppli chain compani sale sourc within hour
product shelf requir less system inventori time concur pg scale
effici help allevi inventori destock pressur nonetheless concern
retail like remain heavili focus ration inventori greater
effici manufactur may enough off-set effect prolong destock cycl
privat label headwind pg manag also acknowledg retail continu step-up
sale privat label product trend believ like continu given increas
prolifer hard discount across aldi lidl news us
manag frank acknowledg pressur demonstr concern particularli
brand hpc compani pg whose product sell signific premium vs broader
categori continu see step privat label penetr threat pg
broader hpc although also expect effect higher privat label penetr
disproportion impact hpc compani other
media suppli chain work continu pg continu overhaul media suppli chain
strong focu drive greater product non-work market spend first
phase consolid conclud pg reduc number agenc
work gener save next phase continu
consolid agenc save anoth all-in
encourag pg remain focus improv effici media suppli chain although
caution reduc media spend via absolut cost reduct and/or increas effici
allevi effect top-line pressur long
market share trend remain mix although pg see improv global
categori growth across pg categori roughli line impli
pg lost share global basi geographi overal categori growth msd across
develop market lsd across develop market said market share trend still
show sign improv volum share in-lin vs last year level
improv develop develop market categori basi manag
indic global categori grow hold volum share all-in see
broad-brush improv volum share encourag although remain concern
pocket persist price weak across pg busi await sustain
recoveri price becom increment posit
gross margin yr/yr estim gross margin
y/i estim fx-neutral basi core gross
margin declin reflect product save off-set
commod cost increas unfavor geograph product mix incl
transport cost headwind unfavor price
sg yr/yr all-in sg forecast fx-neutral
basi core sg decreas save relat overhead agenc fee
advertis product cost partial off-set part higher reinvest spend
organ sale growth expect end manag guidanc
rang manag expect organ sale growth low end previous
issu guidanc rang total ep growth narrow prior
separ pg continu make good improv work capit compani leverag
suppli chain initi expect free cash flow product
prior
first major acquisit sinc pg pay usd cash multipl brand
sever over-the-counter categori complementari pg current over-the-counter portfolio includ pain relief
cold headach busi gener sale grown past two year vs
categori growth acquisit build signific scale oversea product sold
countri primarili europ latin america asia merck shop busi order
invest resourc prescript portfolio deal expect close pg manag
indic deal close end calendar add pg total
sale neutral impact ep beyond pg manag expect acquisit
accret faster growth balanc compani attract margin merck
kgaa asset part pg health segment net sale pre-tax margin
ex corpor expens contain over-the-counter oral product
pg also announc end pgt healthcar joint ventur teva pharmaceut due
differ strateg prioriti pg control jv gener revenu
respect asset return compani re-establish independ over-the-counter busi pg
anticip disrupt distribut anticip transit servic teva take
close deal merck addit transact mean pg asset
categori believ provid pg opportun bring categori new
market someth pg abl previous due geograph restrict associ
jv teva all-in view deal merck kgaa over-the-counter asset posit multipl front
accret pg growth profil long-term give pg scale oversea run
global over-the-counter busi without prior partner teva importantli indic us
board/manag settl take offens transform portfolio believ
signal addit acquisit possibl perhap even larger scale said also
acknowledg acquisit come time pocket pg portfolio includ babi
groom remain signific pressur excit possibl
addit see anecdot poor perform elsewher pg busi
exhibit pg segment organ sale margin trend
chart compani report secur llc estim
exhibit pg segment organ sale margin trend cont
chart compani report secur llc estim
compani report nielsen xaoc includ c-store secur llc
note total organ sale growth data includ pg segment across geographi
pg total compani organ sale growth slow materi follow strong perform ag
lafley first tenur averag period slow
period follow recess pg organ sale growth also lag
significantli behind peer past decad sinc march pg organ sale growth
hpc averag quarter trail peer averag gap
narrow sinc late pg actual outperform peer first time nearli
four year howev pg organ sale growth lag peer averag pg
organ sale slow peer averag acceler resum disappoint trend pg
post organ sale growth lag peer final optimist
recent growth trend across hpc expect pg organ sale growth
exhibit pg organ sale growth slow materi sinc earli
chart compani report secur llc
note right chart hpc averag ex pg includ cl loreal unilev period prior march
march period pg growth display peer yet report
pg like continu under-perform develop market develop market organ sale growth
slow across entir hpc group mani year slow much rapidli pg especi
narrow late calendar gap vs peer widen
calendar pg develop market organ sale growth stay steadi peer group
acceler pg organ sale growth develop market
peer averag pg organ sale growth develop market like
quarterli organ sale performanceconsum take-away retail vs manufactur shipment report nielsenreportedcorrel annual organ sale organ sale growth vs hpc peerspghpc average ex pgpg sorgan sale growth like lag peer procter gambl compani
well level report compani peer asid sinc begin pg
develop market organ sale growth trail peer averag
exhibit pg organ sale growth slow materi develop market lag
chart compani report secur llc
note hpc averag includ cl loreal unilev includ begin march march period
pg growth display peer yet report
pg strategi improv top-lin ceo taylor said acceler top-lin growth pg
press need long term manag goal grow organ sale slightli ahead
market although given today weak result question whether achiev near-term
manag plan acceler top-lin growth follow initi
focus prioriti categori manag focus prioriti behind pg four
largest categori babi fabric hair groom sale
profit pg two largest market unit state china nearli sale
profit
increas number user manag goal top brand grow
user cagni manag said figur unit state
china pg plan drive increas user product superior media reach
effect packag shelf placement sampl pricing/consum valu creation
grow vs take share manag want organ focu drive market
growth vs take market share competitor
improv agil manag push faster decis make give brand
manag single-point respons key part initi
increas transform innov manag believ pg recent put
much focu increment innov vs transform innov addit pg plan
increas support success innov beyond year one
exhibit pg organ sale growth focu categories/countri mix
chart compani report secur llc
pg make notabl progress still room improv save consist
provid bp y/i benefit margin quarter sinc pg origin cost save
plan ran help pg off-set headwind fx materi cost mix
innov capacity/cap invest begin pg began post signific
y/i margin increas includ exclud fx howev sinc y/i margin benefit
subsid due harder comparison commod inflat organiz capabl invest
cost save continu provid margin benefit expect pg re-invest signific
amount next save behind effort boost top line
product/packag sale capability/coverag brand awareness/tri build invest
acceler earli year
exhibit pg cost-sav impact margin
compani report secur llc estim
exhibit pg margin improv slow consider
chart compani report secur llc estim
note data origin report adjust restat
pg continu execut save confer call
manag provid increment detail latest cost save plan origin
announc februari run pg identifi cost save
opportun cog line top save cog save pg achiev
organ sale growth focu categoriesbabi carefabr carehair caregroomingweight organ sale growth focu countriesu chinaweight save gross margin chang bp gross margin changegross margin chang ex oper margin chang bp ebit margin changeebit margin chang ex incremenat reductionin digitaladvertis procter gambl compani
last five year pg deliv cogs-rel save put ahead
raw packag materi save reflect part supplier consolid
simplif compani sku lineups/manufactur platform pg plan reduc number
supplier next two year increas number co-loc supplier
product site supplier current co-loc pg product site
manufactur save broadli speak pg aim reduc manufactur
expens goal reduc head count per case produc pg intern measur
manufactur product cumul next five year top cumul
improv last five year pg also plan reduc number manufactur
platform
transport wareh effici pg expect improv warehous effici
much use digit algorithm plan among thing reduc
inventori result drive superior fill rate across transport network
separ pg identifi save opportun across market budget reflect least
save lower media rate reduct media suppli chain wast
save lower agenc fee ad product cost save tie in-stor
materi direct-to-consum product trial build sampl program
addit pg plan reduct trade spend reflect effici save
spend pool addit overhead save focus reduc activ furthest away
custom total manag identifi cost save potenti five year
period risk-adjust figur
given compani past track record cost contain view compani
program highli achiev believ upsid potenti like howev caution
reduc media trade spend could ultim reduc top-lin growth potenti greatli
need pg would prefer see reinvest save behind high roi market brand
build activ rather outright reduct marketing/trad spend
note addit overhead reduct figur reflect mid-point pg expect
compani report secur llc
fx less headwind top-line earn growth
fx signific drag pg fundament recent year fx neg impact
top line drag ep moder fx modest
drag top-line drag ep fiscal fx net neutral top-line core ep
growth fiscal fx turn posit benefit top-lin benefit
core ep growth fiscal fx tailwind benefit top-lin
benefit core ep growth
compani report secur llc estim
note data origin report adjust restat
fx impact sale epssal impactep impact procter gambl compani
procter gambl compani pg financi guidanc secur llcbonni herzog except per-shar data sourc tabl compani report secur llc estimatesmarket growth sale marketcor ep growth msd hsdadjust greatertot sharehold returntop peer groupcash return save sorigin save end save yearssuppli chain annuallyguid provid juli call octob call januari call april call fy fy market sale end acquisit divestituresflat sale profitoper profit driver ep growth growth itemscommod savingsexpect expenseincreas non-oper incom netdown rate allocationcapit expenditur provid august call octob call novemb day januari call april call fy market sale acquisit sale profitgross margin bpsoper bpsepsep growth growth itemscommod inflationmodest savingsaround expensedown non-oper incom rate coreflatflatslightli yr/yrmiddl allocationcapit expenditur repurchas annual financi targetsfi guidancefi guidanc cosmet household person
price target base follow methodolog forward ev-to-ebitda price-to-earnings analysi
absolut rel discount cash flow analysi
forward ev-to-ebitda absolut rel valuat rang impli ev-to-
ebitda multipl premium compani current forward multipl
discount one-year discount three-year histor averag forward ev-to-
ebitda multipl believ appropri consid pg top-lin challeng balanc high
dividend yield long histori return cash sharehold
forward price-to-earnings absolut rel valuat rang impli price-to-earnings multipl
compani current forward multipl discount one-year
discount three-year histor averag forward price-to-earnings multipl
sum-of-the-part discount also valu pg base sum-of-the-part dcf
analysi appropri valu specif opportun pg differ segment base
analysi believ pg worth beauti hair person segment worth
groom segment worth health segment worth
fabric segment worth babi feminin
famili segment worth
chart factset secur llc
procter gambl pg quarterli earn secur llcbonni herzog except per-shar data sourc tabl compani report secur llc estimatesfisc year end june product non-oper inc earn non-controlling share outstanding- eps- eps- per sale sale ex incom ex eps- eps- eps- ex share outstanding- build total stack organ sale cosmet household person
pg volum average price/unit growth y/i
pg dollar share y/i chang
chart nielsen xaoc includ c-store secur llc
sale y/yavg eq price y/ydollar sale y/i sold promo sold promo y/ydollar sharedollar share y/i bp retailperiod end end end end end end end procter detergent-liquid detergent- soap-light cleanser creme wax rins cleaners-multi style combin shave bodi channel data chang bp dollar share procter gambl compani
exhibit pg european summari data week end
pg european eq volum average price/eq growth
pg european valu share y/i chang
nielsen esp total europ secur llc
exhibit pg categori result period end
note babi diaper china breakdown cover nielsen mass retail univers total china nation exclud
babi store babi diaper specialti breakdown babi store
nielsen scantrack total emerg market secur llc
exhibit pg emerg market valu sale volum average price per growth
note growth rate exclud brazil prior
nielsen scantrack total emerg market secur llc
exhibit pg emerg market valu share y/i chang
nielsen scantrack total emerg market secur llc
price target
price target base price-to-earnings ev/ebitda multipl respect
risk target includ increas competit promot activ macroeconomic slowdown
given pg premium price point fx commod price volatil
pg undergon larg amount organiz chang begin see improv
top line howev share loss continu margin progress slow believ market
fulli valu progress made date
procter gambl co pg base cincinnati oh largest global manufactur market
consum packag good compani produc divers set product beauti
groom health fabric babi feminin famili segment brand
portfolio extrem deep billion-dollar brand brand name includ crest toothpast
gillett razor olay skin care pamper diaper panten hair care tide laundri deterg product
sold countri primarili mass merchandis groceri store club store drug
store high-frequ store neighborhood store develop market
